NEWBURY PARK, Calif.–(BUSINESS WIRE)–Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will showcase its Otolaryngology Advantage™ suite of ENT-specific solutions at the AAO-HNSF Annual Meeting & OTO Experience from September 15-17, 2019 during exhibiting hours in New Orleans, LA.
Designed to maximize efficiencies and improve profitability, Advantage uses real-time data to automate tasks and streamline patient flow. Features include:
“Our goal is to maximize the efficiency of the entire staff during the patient encounter to drive down costs and improve the patient experience,” said Link Wilson, CEO and product architect for Compulink. “Our Advantage SMART Practice solution handles all of the needs of a patient encounter, reducing repetitive steps to enable the practice to see more patients with the same staff and improve their bottom line by as much as 40%.”
Designed specifically for frontline ENT providers, Advantage includes EHR supporting all ENT sub-specialties, practice management, mobile patient engagement, and a comprehensive ASC solution. The company also provides an expert revenue cycle management service for its clients. Advantage is 2015 ONC Certified for MIPS and is used by more than 20,000 providers in over 4,700 locations, 60 ASCs, and 19 universities and colleges.
Attendees at AAO-HNSF can demo Otolaryngology Advantage at booth 1919.
About Compulink Healthcare Solutions
A leader in specialty-specific, all-in-one EHR and Practice Management solutions for 34 years, Compulink’s Advantage SMART Practice® uses artificial intelligence to improve clinical and financial results. Designed to maximize your time while seeing patients, Advantage includes everything you need to optimize workflow including EHR, PM, ASC, patient engagement, and RCM.
Contacts
Compulink Healthcare Solutions
Mary Ann Fitzhugh
p. 800.456.4522
e. press@compulinkadvantage.com
NDA will be primarily based on a single Phase 1 human abuse potential clinical study…
PALO ALTO, CA / ACCESSWIRE / March 27, 2024 / Bioz, Inc., a scientific research-focused…
LUND, SWEDEN / ACCESSWIRE / March 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq…
Relief Therapeutics Calls Extraordinary General Meeting Anticipated Board of Directors OverhaulGENEVA, SWITZERLAND / ACCESSWIRE /…
Pivotal Trial for Improving Overall Function and Quality of LifeSALT LAKE CITY--(BUSINESS WIRE)--#medicaldevices--PhotoPharmics, a pioneer…
Bill passage key to supplemental oxygen access and adequate reimbursementIRVING, TX / ACCESSWIRE / March…